The African Medicines Regulatory Harmonization Initiative: Rationale and Benefits

被引：23
|
作者：
Ndomondo-Sigonda, M. [1 ]
Ambali, A. [1 ]
机构：
[1] African Union NEPAD Agcy, Pretoria, South Africa
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷 / 02期
关键词：
D O I：
10.1038/clpt.2010.299
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Medicines regulation remains an important but neglected component of promotion and protection of public health because it helps to ensure that patients have access to quality, safe, and efficacious medicines. Investing in the African Medicines Regulatory Harmonization (AMRH) initiative provides an opportunity for strengthening regulatory capacity, cost-effective use of the limited financial and human resources, attainment of the three health-related Millennium Development Goals (MDGs), and promotion of trade and socioeconomic development for African countries and regions.
引用
收藏
页码：176 / 178
页数：3
相关论文
共 50 条
12345